Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tucker W. Coston
Observed names:
MD Tucker W. Coston,,
Tucker Coston,
Tucker W Coston
Institution:
Duke Cancer Institute
Observed institutions:
Mayo Clinic,
Mayo Clinic Hospital,
Mayo Clinic in Florida,
Invitae (United States),
Mayo Clinic Comprehensive Cancer Center (Florida),
Duke Cancer Institute,
University of Missouri–Kansas City
show all 7
ORCID:
0000-0002-5843-2506
Observed ORCID:
0000-0002-5843-2506
OpenAlex ID:
A5052124753
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
2019
·
Tucker Coston
, Prateek Pophali
, et al.
·
American Journal of Hematology
·
72
PDF
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience
2023
·
Tucker Coston
, Aakash Desai
, et al.
·
JCO Precision Oncology
·
50
PDF
A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer
2024
·
Osama Mosalem
, Tucker W Coston
, et al.
·
The Oncologist
·
15
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program
2023
·
Jeremy C Jones
, Michael A Golafshar
, et al.
·
Cureus
·
14
PDF
Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma
2024
·
Blake J McKinley
, Tucker W Coston
, et al.
·
The Oncologist
·
8
PDF
Responses to immune checkpoint inhibition among MSI-H pancreatic ductal adenocarcinoma: A multi-institutional case series.
2022
·
Tucker Coston
, Jason S. Starr
, et al.
·
Journal of Clinical Oncology
·
3
An Excellent Response of Microsatellite Instability-High Pancreatic Adenocarcinoma to Pembrolizumab Treatment: The Role of Circulating Tumor DNA Testing
2023
·
Bhrugun Anisetti
, Tucker W Coston
, et al.
·
Cureus
·
2
PDF
Assessment of hematological toxicity in patients with advanced neuroendocrine tumors and extensive/innumerable bone metastases undergoing lutetium-177 DOTATATE treatment.
2024
·
Osama M Mosalem
, Tucker Coston
, et al.
·
Journal of Clinical Oncology
·
1
Delayed brain metastasis in recurrent hepatocellular carcinoma following liver transplantation: a case report highlighting the predictive value of microvascular invasion
2023
·
Bhrugun Anisetti
, Ahmed K. Ahmed
, et al.
·
Clinical Journal of Gastroenterology
·
1
Characterizing bone metastases and skeletal-related events in patients with well-differentiated neuroendocrine neoplasms utilizing Ga68-DOTATE PET.
2023
·
Tucker Coston
, Himil Mahadevia
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Characterizing the genomic landscape of POLE/POLD1-mutated colorectal adenocarcinoma.
2023
·
Tucker Coston
, Elizabeth Mauer
, et al.
·
Journal of Clinical Oncology
·
1
Abstract CT184: Preliminary results of first-line botensilimab (BOT) and balstilimab (BAL) optimization in microsatellite stable colorectal cancer (MSS CRC) without liver, bone, or brain metastasis (BBOpCo)
2026
·
Nicholas C. Devito
, Emily Bolch
, et al.
·
Cancer Research
Characterizing Bone Metastases in Patients with Well-Differentiated Neuroendocrine Neoplasms Utilizing Ga68-DOTATATE PET
2023
·
MD Tucker W. Coston,
, MBBS Himil J. Mahadevia,
, et al.
·
Endocrine Abstracts
Universal genetic testing versus guideline-directed testing for hereditary cancer syndromes among traditionally underrepresented patients in a community oncology program.
2022
·
Jeremy Clifton Jones
, Tucker Coston
, et al.
·
Journal of Clinical Oncology
37-Year-Old Man With an Altered Level of Consciousness
2021
·
Hadiyah Y. Audil
, Tucker W. Coston
, et al.
·
Mayo Clinic Proceedings
PDF
Show more works
View as search
Works count:
15
Citation count:
168
H-index:
5
I10-index:
4
Year
Topic
Type
